FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-203 | 70004-203-32 | Fentanyl Citrate | .02 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-229 | 70004-229-32 | Fentanyl Citrate | .01 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-229 | 70004-229-40 | Fentanyl Citrate | .01 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-06 | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-16 | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-17 | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-222 | 70004-222-30 | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-200 | 70004-200-32 | Fentanyl Citrate | .05 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-202 | 70004-202-22 | Fentanyl Citrate | .01 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; 4 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-253 | 70004-253-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-254 | 70004-254-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-244 | 70004-244-40 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; .625 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | .005 mg/1 mL; .75 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-264 | 70004-264-22 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-260 | 70004-260-32 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-638 | 70004-638-09 | Glycopyrrolate | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-30 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-63 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-63 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-62 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-55 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-30 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 50 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 5 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 20 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-380 | 70004-380-05 | Methadone Hydrochloride | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-16 | Morphine Sulfate | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-63 | Morphine Sulfate | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-62 | Morphine Sulfate | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-59 | Morphine Sulfate | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-103 | 70004-103-16 | Morphine Sulfate | 5 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "STAQ Pharma of Ohio, LLC(118684089)" | 83340-108 | 83340-108-03 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Ascorbic Acid | 500 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Ascorbic Acid | 500 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "STASKA PHARMACEUTICALS, INC.(099939403)" | Ascorbic Acid | 500 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 |